Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-30 @ 4:41 AM
Study NCT ID:
NCT07328451
Status:
RECRUITING
Last Update Posted:
2026-02-23
First Post:
2025-12-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
Sponsor:
Denali Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-24
First Submit QC Date:
None
Study First Post Date:
2026-01-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-20
Last Update Post Date:
2026-02-23
Last Update Post Date Type:
ACTUAL